PINE BM CO.,LTD.S17.A99From 2011, PINE BM's journey of Korean leading regenerative medical solution provider has started.
With Korean-standard high quality biocompatible medical device, PINE BM is actively supplying its absorbable sutures to all Korean major hospitals including the "BIG 5" and university hospitals.
CE MDR is expected to be obtained in the first half of 2026 while CE MDD extension is till the end of 2027. ISO13485 and GMP are the footprint of PINE BM's high quality.
PINE BM is exporting to more than 30 countries such as Germany, Switzerland, Japan, United States, etc.
